Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
An. pediatr. (2003, Ed. impr.) ; 76(6): 350-354, jun. 2012. tab, graf
Artigo em Espanhol | IBECS | ID: ibc-101489

RESUMO

Tras estar prácticamente erradicado en Europa, en los últimos 3 años han aparecido miles de casos de sarampión autóctono. Se describen los casos ocurridos en la zona norte de Madrid (enero-junio de 2011).Se informa de 22 casos, 18 de ellos agrupados en 2 brotes (2 escuelas infantiles). La tasa de ataque del principal fue del 29%.Todos fueron en pacientes no vacunados (mediana=14 meses). El genotipo predominante fue el D4 (95%). Hubo un 45% de complicaciones y un 45% de ingresos. El Servicio de Salud Pública recomendó aislar a los casos y vacunó anticipadamente a los contactos susceptibles. En los centros sanitarios se estableció un circuito específico para atender a los casos sospechosos. Se ha adelantado la vacunación triple vírica de los 15 a los 12 meses en la Comunidad de Madrid. El sarampión es una enfermedad re-emergente en Europa. El manejo coordinado entre Salud Pública y los centros asistenciales es fundamental para limitar los brotes(AU)


After being virtually eradicated in Europe, thousands of cases of measles in the population of Spanish origin have appeared in the last 3 years. We describe the cases diagnosed in the north of Madrid between January and June 2011. A total of 22 cases are reported, 18 of them grouped in 2 outbreaks (2 nurseries). The primary attack rate was 29% in the main outbreak. All cases were in unvaccinated patients (median = 14 months). Genotype D4 was predominant (95%). There was a 45% complication rate and 45% were admitted to hospitals. The Public Health Service recommended isolating cases and vaccinating susceptible contacts in advance. Health Centres established a specific protocol to respond to suspected cases. The Measles vaccination has been brought forward from 15 to 12 months in Madrid. Measles is a re-emerging disease in Europe. The coordinated management between public health and health facilities is essential to limiting outbreaks(AU)


Assuntos
Humanos , Masculino , Feminino , Criança , Sarampo/diagnóstico , Sarampo/epidemiologia , Sarampo/microbiologia , Escolas Maternais , Vacina contra Sarampo/uso terapêutico , Vacina contra Sarampo-Caxumba-Rubéola/uso terapêutico , Surtos de Doenças/estatística & dados numéricos
2.
An Pediatr (Barc) ; 76(6): 350-4, 2012 Jun.
Artigo em Espanhol | MEDLINE | ID: mdl-22265376

RESUMO

After being virtually eradicated in Europe, thousands of cases of measles in the population of Spanish origin have appeared in the last 3 years. We describe the cases diagnosed in the north of Madrid between January and June 2011. A total of 22 cases are reported, 18 of them grouped in 2 outbreaks (2 nurseries). The primary attack rate was 29% in the main outbreak. All cases were in unvaccinated patients (median = 14 months). Genotype D4 was predominant (95%). There was a 45% complication rate and 45% were admitted to hospitals. The Public Health Service recommended isolating cases and vaccinating susceptible contacts in advance. Health Centres established a specific protocol to respond to suspected cases. The Measles vaccination has been brought forward from 15 to 12 months in Madrid. Measles is a re-emerging disease in Europe. The coordinated management between public health and health facilities is essential to limiting outbreaks.


Assuntos
Surtos de Doenças , Sarampo/epidemiologia , Humanos , Lactente , Estudos Prospectivos , Estudos Retrospectivos , Espanha/epidemiologia , Saúde da População Urbana
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...